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areas, including the field of molecu-
lar parasitology (Borst, 2002). We 
hope that other enigmatic epigenetic 
mechanisms, such as those that con-
trol variable rates of var gene switching 
(Horrocks et al., 2004) will not remain 
an eternal mystery.
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The migration of hematopoietic stem 
cells (HSCs) is evident in several cir-
cumstances. During development, 
HSCs seed new sites of hematopoi-
esis, and under physiological condi-
tions in adult life, HSCs continuously 
move between the bone marrow 
and the bloodstream. Also, a mas-
sive efflux of HSCs, a process called 
mobilization, occurs following treat-
ment with cytotoxic drugs or cytokines 
such as granulocyte colony-stimulat-
ing factor (G-CSF), whereas follow-
ing intravenous injection into trans-
plant recipients, HSCs migrate to and 
engraft in the bone marrow. Although 
the mobilization and transplantation of 
HSCs is widely used in modern clini-
cal medicine, the precise mechanisms 
by which HSCs exit their niche or re-
engage their niche after transplanta-
tion are still being unraveled. Katayama 
et al. (2006) now report that the sym-
pathetic nervous system is a key and 
previously unrecognized participant in 
HSC mobilization.
As a result of more than four decades 
of studies using mostly rodent models 
and an equally long clinical tradition 
of bone-marrow transplantation regi-
mens, HSCs are the best characterized 
population of stem cells. However, the 
field has been held back by an impre-
cise understanding of the microenvi-
ronment, or niche, in which the HSCs 
reside. This, for obvious reasons, has 
hampered detailed investigation of the 
mobilization and engraftment process. 
Studies of the HSC microenvironment 
have been limited by the fact that the 
most liquid of tissues, bone marrow, is 
encased by the most solid. By label-
ing stem cells and reinfusing them, it 
has been shown that HSCs reside in 
close proximity to the endosteal bone 
surface, and the assumption has been 
made that maturing cells become 
redistributed toward the central marrow 
region. Recently, two genetic studies 
identified osteoblasts as crucial cellu-
lar components of the HSC microenvi-
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In this issue of Cell, Katayama et al. (2006) report a new regulatory axis for the mobiliza-
tion of hematopoietic stem cells that links these cells to the nervous system and bone in 
an unanticipated way. The new findings suggest that the nervous system, which has the 
inherent ability to integrate information from throughout the organism, may govern the local 
relationship between stem cells and their niches.
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ronment and thus have defined a niche 
for HSCs (Zhang et al., 2003; Calvi et 
al., 2003). Subsequently, advanced 
imaging studies have demonstrated 
that the HSCs reside in close proxim-
ity to the bone-lining osteoblasts (Arai 
et al., 2004) as well as blood vessels, 
which may constitute an alternative 
niche (Kiel et al., 2005). New insights 
into the mechanisms by which HSCs 
egress from (or are retained by) the 
niche are likely to emerge from these 
anatomical descriptions.
The cytokine G-CSF is the most 
widely used mobilizing agent for HSCs 
in experimental as well as clinical set-
tings. It has been postulated that G-
CSF triggers the release of specific 
proteases, leading to the degradation 
of adhesion molecules and chemo-
kines. In particular, CXCL12 or stro-
mal-derived factor 1 (SDF-1) and its 
receptor CXCR4 have been implicated 
as a key ligand-receptor pair respon-
sible for retention of HSCs in the bone 
marrow (Papayannopoulou, 2004). 
However, mice deficient in several of 
these proteases exhibit normal G-
CSF-induced mobilization of HSCs, 
indicating that other, as yet unknown, 
mechanisms must be involved. Given 
that the ability to mobilize stem cells 
varies between patients, these pro-
cesses beg further investigation. 
The work of Katayama et al. (2006) 
takes a step into this void, provid-
ing a mechanism for G-CSF-induced 
mobilization of HSCs and suggesting 
that the sympathetic nervous sys-
tem may regulate stem cell traffick-
ing. Remarkably, the study started 
out from a completely different angle 
before arriving at these unanticipated 
and intriguing conclusions.
Several years ago, Paul Frenette 
and his group observed that the sul-
fated fucose polymer fucoidan causes 
rapid mobilization of HSCs (Frenette 
and Weiss, 2000). In order to assess 
whether a very similar molecule syn-
thesized by mammalian cells, a sul-
fated galactolipid called sulfatide, 
might contribute to the endogenous 
mobilization process, Frenette and 
colleagues studied mice deficient in 
the UDP-galactose:ceramide galac-
tosyltransferase (Cgt). Cgt is essential 
for the synthesis of sulfatide by medi-
ating the addition of UDP-galactose to 
ceramide. The authors found that mice 
lacking Cgt exhibited severely impaired 
mobilization in response to G-CSF. 
Unexpectedly, they found that the 
mobilization defect in mice lacking Cgt 
could not be linked to the lack of sulfa-
tide and that another indirect mecha-
nism had to be involved. The products 
of Cgt contribute to the myelin sheath 
surrounding nerves, and Cgt-deficient 
mice exhibit defective nerve transmis-
sion. Frenette and colleagues specu-
lated that impaired transmission of 
nervous-system signals could play a 
role in the mobilization defect. In fact, 
this was not an entirely farfetched 
hypothesis for several reasons. First, 
a role for the sympathetic nervous 
system in regulating bone formation 
is well established, and it has been 
elegantly demonstrated that adrener-
gic signals directly regulate osteoblast 
function (Takeda et al., 2002). Sec-
figure 1. signals from the sympathetic nervous system modulate localization of 
Hematopoietic stem cells to the endosteal niche in Bone
G-CSF activation of peripheral noradrenergic neurons (thick green arrow) together with an unknown 
mechanism (green dashed arrow) induces mobilization of hematopoietic stem cells (HSCs) through 
suppression of osteoblasts and a decrease in CXCL12. HSC mobilization by G-CSF was studied in 
mouse models with defects in nerve conduction (Katayama et al., 2006). These models included 
mice deficient in the UDP-galactose:ceramide galactosyltransferase (Cgt−/−); mice deficient in do-
pamine β-hydroxylase (Dbh−/−); mice injected postnatally with 6-hydroxydopamine (6OHDA), which 
disrupts catecholaminergic neurons; and mice treated with β blockers (β antagonists). Additionally, 
a β2-adrenergic agonist rescues the mobilization defects in mice deficient in dopamine β-hydroxy-
lase and augments G-CSF-induced mobilization in control mice. These studies demonstrate that 
noradrenergic signals from the sympathetic nervous system are critical mediators of G-CSF-induced 
mobilization.
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ond, HSCs reside in close proximity to 
osteoblasts at the endosteal surface. 
Third, the authors have demonstrated 
that G-CSF treatment causes sup-
pression of osteoblasts, leading to a 
decrease in the chemokine CXCL12. 
Normally, CXCL12 is highly expressed 
in bone tissues and is believed to be 
critical for the attraction of HSCs to the 
niche. Similar findings were recently 
reported in an independent study by 
Semerad and colleagues (Semerad 
et al., 2005). In order to back up their 
theory that the nervous system has 
a role in mediating HSC mobilization, 
Katayama et al. (2006) examined a 
battery of genetic and pharmaco-
logical mouse models with impaired 
nerve conduction in addition to the 
mice lacking Cgt. These included 
mice lacking dopamine β-hydroxylase 
(Dbh−/−), which have deficient synthe-
sis of norepinephrine; mice subjected 
to pharmacological disruption of cat-
echolaminergic neurons through post-
natal injections of 6-hydroxydopamine 
(6OHDA); and mice treated with β
blockers (Figure 1). Each of the mod-
els resulted in decreased HSC mobi-
lization in response to G-CSF. Osteo-
blast suppression was not observed 
in these models, and CXCL12 levels 
remained intact. This strongly sug-
gests that noradrenergic signals from 
the sympathetic nervous system are 
critical mediators of G-CSF-induced 
mobilization (Figure 1). Involvement 
of noradrenergic activity was further 
supported by the observation that 
norepinephrine levels decreased in 
the bone following G-CSF stimula-
tion, a sign that norepinephrine was 
depleted through its release. Addi-
tionally, a β2-adrenergic agonist could 
rescue the mobilization defects in mice 
lacking dopamine β-hydroxylase and 
caused an overall augmentation of G-
CSF-induced mobilization in control 
mice (Figure 1). Importantly, however, 
adrenergic stimulation in the absence 
of G-CSF treatment could not induce 
mobilization, suggesting that the sym-
pathetic nervous system is not the sole 
downstream target of G-CSF and that 
another, as yet unidentified, parallel 
mechanism of mobilization must exist.
The findings by Katayama et al. 
(2006) suggest that the pharmacologi-
cal manipulation of the sympathetic 
nervous system may be a means of 
therapeutically targeting the stem cells 
in their niche for the purpose of either 
mobilization or, conversely, attracting 
stem cells to the niche following trans-
plantation. Because adrenergic ago-
nists and antagonists exist and have 
been used in the clinic without major 
deleterious effects, such trials may 
become a reality in the near future. 
However, the implication of greatest 
importance may be in a more generic 
biological context: Given that hema-
topoiesis occurs at multiple locations 
in the bones throughout the body, it 
has not been clear how hematopoietic 
homeostasis is maintained. The con-
tinuous migration of HSCs between 
bone marrow and the bloodstream 
that occurs under normal physiologi-
cal conditions (Wright et al., 2001) 
could serve to maintain hematopoi-
etic homeostasis. HSC niches that are 
left empty following stem cell death 
or differentiation can be reseeded by 
circulating stem cells released from 
other niches, but such trafficking must 
occur under a certain level of systemic 
control. Given the new findings, it is 
tempting to speculate that the nervous 
system could play an important role in 
regulating hematopoietic homeostasis 
by influencing the migration and local-
ization of stem cells among different 
bone-marrow niches.
From the groundbreaking nature of 
the Katayama et al. study, there fol-
lows naturally a number of loose ends 
and questions that require further 
investigation. Perhaps the most impor-
tant task will be to define how G-CSF 
interacts with its neuronal targets. The 
authors demonstrate convincingly that 
neuronal activation by G-CSF occurs 
in the peripheral rather than the cen-
tral nervous system, but, as they point 
out, it is not clear whether G-CSF acts 
directly on neurons or through adja-
cent glial cells or other indirect targets. 
Furthermore, it will be interesting to 
determine whether the mechanisms 
of neuronal regulation also apply to 
HSCs that have a perivascular localiza-
tion (Kiel et al., 2005) in addition to the 
osteoblastic niche that was examined 
here. Specialized vascular domains 
with high CXCL12 content have been 
identified in the bone-marrow vascula-
ture, which may serve as ports of entry 
for circulating stem cells (Sipkins et al., 
2005). It is an attractive idea that these 
particular domains may be subject to 
regulation by the sympathetic nervous 
system. Finally, it will be important to 
identify the missing variables that act 
downstream of G-CSF, which, together 
with sympathetic signals, modulate the 
mobilization process.
Nevertheless, the stage is now set 
for creative science for both experi-
mental and clinical investigators in the 
field. To start with, we will all have to 
reset our thinking about the fundamen-
tal interactions in the bone-marrow 
niche that affect the mobility of stem 
cells. Bone marrow, bone, and the ner-
vous system now appear to integrate 
signals to regulate HSCs. If hematopoi-
esis is any guide, niches may be nodal 
points where multiple, previously dis-
connected systems collide.
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